CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 136 filers reported holding CULLINAN ONCOLOGY INC in Q2 2024. The put-call ratio across all filers is 0.21 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $30,145,825 | +5228.7% | 1,728,545 | +5106.5% | 0.01% | – |
| Q1 2024 | $565,728 | +28.0% | 33,200 | -23.5% | 0.00% | – |
| Q4 2023 | $442,042 | +11.7% | 43,380 | -0.8% | 0.00% | – |
| Q3 2023 | $395,847 | -15.9% | 43,740 | 0.0% | 0.00% | – |
| Q2 2023 | $470,642 | +40.7% | 43,740 | +33.8% | 0.00% | – |
| Q1 2023 | $334,521 | +12.4% | 32,700 | +16.0% | 0.00% | – |
| Q4 2022 | $297,510 | -13.0% | 28,200 | +5.6% | 0.00% | – |
| Q3 2022 | $342,000 | +9.6% | 26,700 | +9.9% | 0.00% | – |
| Q2 2022 | $312,000 | +110.8% | 24,300 | +72.3% | 0.00% | – |
| Q1 2022 | $148,000 | -39.6% | 14,100 | -11.3% | 0.00% | – |
| Q4 2021 | $245,000 | -21.2% | 15,900 | +15.2% | 0.00% | – |
| Q3 2021 | $311,000 | -12.4% | 13,800 | 0.0% | 0.00% | – |
| Q2 2021 | $355,000 | – | 13,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $80,689,227 | 20.93% |
| CHI Advisors LLC | 3,317,544 | $35,000,089 | 9.32% |
| Nextech Invest Ltd. | 1,221,145 | $12,883,080 | 5.12% |
| BVF INC/IL | 7,509,059 | $79,220,572 | 3.34% |
| TANG CAPITAL MANAGEMENT LLC | 809,231 | $8,537,387 | 1.24% |
| SVB FINANCIAL GROUP | 27,032 | $285,188 | 0.78% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 229,416 | $2,420,339 | 0.69% |
| Boxer Capital, LLC | 1,074,082 | $11,331,565 | 0.60% |
| Atom Investors LP | 107,193 | $1,130,886 | 0.56% |
| HighVista Strategies LLC | 79,918 | $843,135 | 0.50% |